Streptococcus pneumoniae carriage in the Gaza strip

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Regev Yochay, Gili ^a,b   Abullaish, Izzeldin ^b,f   Malley, Richard ^c   Shainberg, Bracha ^d   Varon, Miriam ^e   Roytman, Yulia ^a   Ziv, Arnona ^b   Goral, Aviva ^a,b   Elhamdany, Abedallah ^g   Rahav, Galia ^a   Raz, Meir ^e  

^a TEL AVIV UNIVERSITY   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d Central Laboratory   (Israel)

^e Jerusalem Hashfela District   (Israel)

^f UNIVERSITY OF TORONTO   (Canada)

^g Keystone Consulting Agency   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CROSS-SECTIONAL STUDY; DRUG USE; EPIDEMIOLOGICAL DATA; FEMALE; GAZA STRIP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NASOPHARYNX; NONHUMAN; PALESTINE; PARENT; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PREVALENCE; SCREENING; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; ADULT; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE EAST; SEROTYPING;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MIDDLE EAST; NASOPHARYNX; PENICILLINS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84859947190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035061     Document Type: Article

References (36)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
2. Bogaert D, De Groot R, Hermans PW, (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154.
3. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. (2010) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41.
4. Flasche S, Van Hoek AJ, Sheasby E, Waight P, Andrews N, et al. (2011) Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 8: e1001017.
5. Spijkerman J, van Gils EJ, Veenhoven RH, Hak E, Yzerman EP, et al. (2011) Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 17: 584-591.
6. Vestrheim DF, Hoiby EA, Aaberge IS, Caugant DA, (2010) Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol 17: 325-334.
7. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, et al. (2009) Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124: e1-11.
8. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, et al. (2005) Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116: e408-413.
9. Regev-Yochay G, Raz M, Shainberg B, Dagan R, Varon M, et al. (2003) Independent risk factors for carriage of penicillin-non-susceptible Streptococcus pneumoniae. Scand J Infect Dis 35: 219-222.
10. Labout JA, Duijts L, Arends LR, Jaddoe VW, Hofman A, et al. (2008) Factors associated with pneumococcal carriage in healthy Dutch infants: the generation R study. J Pediatr 153: 771-776.
11. Regev-Yochay G, Raz M, Dagan R, Porat N, Shainberg B, et al. (2004) Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 38: 632-639.
12. Millar EV, O'Brien KL, Zell ER, Bronsdon MA, Reid R, et al. (2009) Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 28: 711-716.
13. Jacoby P, Carville KS, Hall G, Riley TV, Bowman J, et al. (2011) Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian Aboriginal and non-Aboriginal children. Pediatr Infect Dis J 30: 480-485.
14. Hill PC, Akisanya A, Sankareh K, Cheung YB, Saaka M, et al. (2006) Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 43: 673-679.
15. el-Astal Z, Khamis N, Peled N, Dagan R, Yagupsky P, (1997) Antimicrobial resistance and typing of pneumococci in Gaza Strip children. Pediatr Infect Dis J 16: 905-907.
16. Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA, (2009) Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria. Clin Infect Dis 48 (Suppl 2): S190-196.
17. Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, et al. (2009) Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Clin Infect Dis 48 (Suppl 2): S153-161.
18. Granat SM, Mia Z, Ollgren J, Herva E, Das M, et al. (2007) Longitudinal study on pneumococcal carriage during the first year of life in Bangladesh. Pediatr Infect Dis J 26: 319-324.
19. Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, et al. (2006) Pneumococcal vaccination in developing countries. Lancet 367: 1880-1882.
20. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146.
21. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349: 1341-1348.
22. Weinberger DM, Malley R, Lipsitch M, (2011) Serotype replacement in disease after pneumococcal vaccination. Lancet.
23. Kim SY, Lee G, Goldie SJ, (2010) Economic evaluation of pneumococcal conjugate vaccination in The Gambia. BMC Infect Dis 10: 260.
24. Yildirim I, Hanage WP, Lipsitch M, Shea KM, Stevenson A, et al. (2010) Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 29: 283-288.
25. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, et al. (2004) Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 190: 1203-1211.
26. Lagos R, Munoz A, San Martin O, Maldonado A, Hormazabal JC, et al. (2008) Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994-2007. J Infect Dis 198: 1809-1817.
27. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, et al. (2005) Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun 73: 431-435.
28. Weinberger DM, Harboe ZB, Sanders EA, Ndiritu M, Klugman KP, et al. (2010) Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 51: 692-699.
29. Dagan R, Givon-Lavi N, Greenberg D, Fritzell B, Siegrist CA, (2010) Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis 201: 1570-1579.
30. Tyrrell GJ, Lovgren M, Chui N, Minion J, Garg S, et al. (2009) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine 27: 3553-3560.
31. Dagan R, Klugman KP, (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8: 785-795.
32. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, et al. (2004) Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113: 443-449.
33. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, et al. (2004) Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 39: 641-648.
34. Hsu KK, Shea KM, Stevenson AE, Pelton SI, (2010) Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J 29: 289-293.
35. Simoes AS, Pereira L, Nunes S, Brito-Avo A, de Lencastre H, et al. (2011) Clonal evolution leading to maintenance of antibiotic resistance rates among colonizing Pneumococci in the PCV7 era in Portugal. J Clin Microbiol 49: 2810-2817.
36. Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, et al. (2011) The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 30: 551-555.